Plain-English translation of NCT06693310 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing whether people with ulcerative colitis who are in deep remission—meaning their disease is completely quiet with no signs of inflammation in the colon—can safely reduce or stop their medications. You would either choose to lower your medication doses (or stop them completely) or continue taking what you're currently taking, and the research team would carefully monitor you for two years to see how you do.
Many people with ulcerative colitis worry about being on strong medications long-term. This study is trying to find out whether it's safe to use less medication—or even stop it—for people whose disease is truly well controlled, which could improve quality of life and reduce side effects.
You likely qualify if…
You likely don't qualify if…
You would meet with the research team and choose whether you want to try reducing your medications or keep taking them as you currently do. Over 24 months, you would have regular visits and monitoring (including blood tests and possibly colonoscopies) to make sure you stay well. After that, if you remain in remission, the team would continue following your health through your routine clinical care for an additional 5 years.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States